glp 1/gip agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight GLP-1 receptor agonists are increasingly
Description
cAMP: cyclic adenosine monophosphate
They also act on the brain to reduce appetite
This reduces the risk of hypoglycemia (low blood sugar)
These newer molecules consistently outperform single GLP-1RAs in regards to glycemic control and weight loss (205207), although they exhibit similar gastrointestinal (GI) side effects
Clevel Clin J Med
M.RoitmanM
